Metformin treatment in young children with fragile X syndrome

Metformin treatment in young children with fragile X syndrome

Abstract Background Metformin is a drug commonly used in individuals with type 2 diabetes, obesity, and impaired glucose tolerance. It has a strong safety profile in both children and adults. Studies utilizing the Drosophila model and knock out mouse model of fragile X syndrome (FXS) have found metf...

Full description

Bibliographic Details
Main Authors: Hazel Maridith B. Biag, Laura A. Potter, Victoria Wilkins, Sumra Afzal, Alexis Rosvall, Maria Jimena Salcedo‐Arellano, Akash Rajaratnam, Ramiro Manzano‐Nunez, Andrea Schneider, Flora Tassone, Susan M. Rivera, Randi J. Hagerman
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
FMR1
fragile X syndrome
metformin
targeted treatments
translational medicine
Online Access:https://doi.org/10.1002/mgg3.956

Internet

https://doi.org/10.1002/mgg3.956

Similar Items